Antivirais

Antiviral therapy

Texto completo disponível apenas em PDF.

• O tema
  Doenças causadas por vírus representam dificuldades terapêuticas. O conjunto de medicamentos antivirals disponíveis é ainda relativamente pequeno, mas tem crescido nos últimos anos em razão de enormes investimentos materiais e de talentos: a síndrome da imunodeficiência adquirida é, certamente, o motivo principal dessa procura, mas não o único. Com a presente atualização, dedicada a oftalmologistas, o modo de ação, as aplicações, os efeitos adversos, as apresentações e a posologia dos principais quimioterápicos desse grupo, assim como novidades e perspectivas, são resumidas de modo interessante e de fácil leitura.

REFERÊNCIAS BIBLIOGRÁFICAS

• ¹
  ARONSON, S.; MOORE, T. - Antiviral properties of idoxuridine during steroid treatment of herpes stromal keratitis. Ann. N Y Acad. Sci. 1970; 173:96-101.
• ²
  BALFOUR, H.; BEAN, B.; MITCHELL, C.; SACHS, G.; BOEN, J.; EDELMAN, C. - Acyclovir in immunocompromised patients with cytomegalovirus disease. Am. J. Med. 1982; 73 (suppl. 1A): 241-248.
• ³
  BEYER, C.; ARENS, M.; HILL, G.; ROSE, B.; BEYER, L. - Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits alter penetrating keratoplasty. Arch. Ophthalmol. 1989; 107: 1200-1205.
• ⁴
  BLUMENKRANZ, M.; CULBERTSON, W.; CLARKSON, J. - Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology 1986; 93:296-300.
• ⁵
  BOSTON INTERHOSPITAL VIRUS STUDY GROUP AND THE NIAID-SPONSORED COOPERATIVE ANTIVIRAL CLINICAL STUDY - Failure of high-dose 5-iodo-2'-deoxyuridine in the treatment of herpes simplex virus encephalitis. Evidence of unaccectable toxicity. Repost, 1975.
• ⁶
  CHATIS, P.; MILLER, C.; SCHAGER, L.; CRUMPACKER, C. - Successful treatment with foscamet of an acyclovir-resistant mucocutaneous infection woth herpes simplex virus in a patient with AIDS. N. Engl. J. Med. 1989; 320:297-300.
• ⁷
  COBO, L.; FOLKS, G.; LIESEGANG, T.; LASS, J. - Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 1985; 93:763-767.
• ⁸
  COLLUM, L.; LOGAN, P.; RAVENSCROFT, T. - Acyclovir (Zovirax) in herpetic disciform keratitis. Br. J. Ophthalmol. 1983;67: 115-118.
• ⁹
  COOLEY, T.; KUNCHES, L.; SAUNDERS, V.; RITTER, J.; PERKINS, C.; McLAREN, R. - Oncedaily administration of 2'-3' dideoxyinosine in patients with AIDS or AIDS-related complex. New. Engl. J. Med. 1990; 322: 1340-1345.
• ¹⁰
  CRUMPACKER, C.; SCHNIPPER, L.; ZAIA, J.; LEVIN, M. - Growth inhibition by acycloguanosine of herpes isolated from human infections. Antimicrob. Agents Chemoth. 1979; 15:642-645
• ¹¹
  CULBERTSON, W.; BLUMENKRANZ, M.; PEPOSE, J.; STEWART, J.; CURTIN, V. - Varicella zoster virus is a cause of acute necrosis syndrome. Ophthalmology 1986; 93:559-569.
• ¹²
  DAVIS, G.; HOOFNAGLE, J. - Interferon in viral hepatitis: role in pathogenesis and treatment, Hepatol. 1986; 6: 1038-1041.
• ¹³
  DeCLERCK, E.; DESCAMPS, J.; VERHERST, G.; WALKER, R.; JONES, A. - Comparative eflicacy of antiherpes drugs against different strains of herpessimplex virus. J. Infect. Dis. 1980; 141:563-574.
• ¹⁴
  DERAY, G.; MARTINEZ, F.; KATLAMA, C. B. M. L.; BEAUFILS, H.; DANIS, M. - Foscamet nephrotoxity: mechanism, incidence and prevention. Am. J. Nephrol. 1989; 9:316-321.
• ¹⁵
  DRACH, J. - Targets for the design of antiviral agents. In: DeCLERCK, E. ed. Purine nucleoside analogs as antiviral agents. New York: Plenum press, 1983:231-257.
• ¹⁶
  DUNKLE, L.; ARVIN, A.; WHITLEY, R. - A controlled trial of acyclovir for chickenpox in normal children. N. Engl. J. Med. 1991; 325: 1539-1544.
• ¹⁷
  ELION, G.; FURMAN, P.; FYFE, J.; DE MIRANDA, P.; BEAUCHAMP, L.; SCHAFFER, H. - Selectivity of action of an antiherpetic agent. Proc. Natl. Acad. Sci. USA 1977; 74:5716-5720.
• ¹⁸
  FURMAN, P.; SAINT-CLAIR, M.; FYFE, J. - Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2 -hydroxyethoxymethyl) guanine and its triphosphate. J. Virol. 1979; 32:72-79.
• ¹⁹
  GAUIRI, K. - Anti-herpesvirus polychemotherapy. Adv. Ophthalmol. 1979; 38: 151-160.
• ²⁰
  GERSHON, A.; STEINBERGER, S.; BRUNELL, P. - Zoster immune globulin. A further assessment. N. Engl. J. Med. 1974; 290:243-245.
• ²¹
  HEIDELBERGER, C.; KING, D. - Trifluorothymidine. Pharmacol. Ther. 1979; 6:427-431.
• ²²
  HELGSTRAND, E.; ERICSON, B.; JOHANSSON, N, etal. - Trisodium phosphonormate, a newantiviral compound. Science 1979; 201:819-821.
• ²³
  HIRST, L.; BEYER, T.; WATERS, D.; FLEISHMAN, J. - Successfull management of acute retinal necrosis with intravenous acyclovir. Arch. Ophthalmol. 1987; 19;445-448.
• ²⁴
  HOLLAND, G.; SALAMOTO, M.; HARDY, D.; SIDIKARO, Y.; KREIGER, A.; FRENKEL, L. - Treatment of cytomegalovirus retinopathy in patients with AIDS. Arch. Ophthalmol. 1986; 104: 1794-1800.
• ²⁵
  ISSACS, A.; LINDENMANN, J. - Virus interference. I. The interferon. Proc. R. Soc. London Ser. 1957; 147:258-267.
• ²⁶
  JACOBSON, M.; O'DONNELL, J.; MILLS, J. Foscartnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency y syndrome. Antimicrob. Agents Chemother. 1989; 33:136-141.
• ²⁷
  JOKLIK, W. - Interferons. In: KNIPE, D., ed. Fields Virology. 2^nd ed. New York:: Raven Press, 1990: 383-410.
• ²⁸
  KAPLAN, A.; BEN-PORAT, T. - Mode of antiviral action of 5-ioduracil deoxyriboside. J. Mol. Biol. 1966; 19:320-329.
• ²⁹
  KAUFMAN, H. - Chemotherapy of herpes keratitis. Invest. Ophthalmol. Vis. Sci. 1963; 2:504-508.
• ³⁰
  KAUFMAN, H. - In vivo studies with antiviral agents. Ann. N Y Acad. 1965; 130: 168-113.
• ³¹
  KAUFMAN, H.; MARTOLA, E.; DOHMAN, C. Use of 5-iodo-2' deoxyuridine (IDU) in the treatment of herpessimplex keratitis. Arch. Ophthalmol. 1962; 68:235-239.
• ³²
  KLUG, G. - Architectural design of spherical viruses. Nature 1983; 303:313-401.
• ³³
  LARDER, B.; CHESEBRO, B.; RICHMAN, D. - Susceptibilities of zidovudineo-susceptible and - resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Antimicrob. Agents Chemoth. 1990; 34:436-441.
• ³⁴
  LARSSON, A.; OBERG, B. - Selective activity of herpesvirus DNA synthesis by Foscamet. Antiviral Res. 1981; 1:55-62.
• ³⁵
  LASKIN, O.; CEDERBERG, D.; MILLS, J.; ERON, L.; MILDVAN, D.; SPECTOR, S. - Ganciclovir for the treatment and supression of serious infection caused by cytomegalovirus. Am. J. Med. 1981; 83:201 -201.
• ³⁶
  MACHIDA, H.; KUKINAKA, A.; YOSHINO, H. - Inhibitory effects of antiherpesviral thymidine kinase analogs against varicella-zoster virus. Antimicrob. Agents Chemother. 1982; 21:358-361.
• ³⁷
  MARKER, S.; HOWARD, R.; GROTH, K.; MASTRI, A.; SIMMONS, R.; BALFOUR Jr., H. - A trial of vidarabine for cytomegalovirus infection in renal transplant patients. Arch. Int. Med. 1980; 140: 1441-1444.
• ³⁸
  MAUGDAL, P.; DeCLERCK, E.; DESCAMPS, J. - Experimental herpes simplex stromal keratitis: influence of treatment with topical bromovinyldeoxyuridine and trifuridine. Arch. Ophthalmol. 1982; 100:653-660.
• ³⁹
  MAUGDAL, P.; DeCLERCK, E.; MISSOTTEN, L. - Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicellazoster virus eye infections. INTERNATIONAL SYMPOSIUM ON ANTIVIRAL COMPOUND ANO WOUND HEALING. HAMBURG, 1983.
• ⁴⁰
  MOORE, R.; HIDALGO, J.; SUGLAND, B. - Zidovudine and the natural history of the adquires immunodeficiency syndrome. N. Engl. J. Med. 1991; 324: 1412-1416.
• ⁴¹
  PAVAN-LANGSTON, D.; CAMPBELL,L.; LASS, J. - Acyclovir antimetabolite therapy of experimental herpes simplex keratitis. Am. J. Ophthalmol. 1978; 86:618-623.
• ⁴²
  PAVAN-LANGSTON, O.; PARK, N.; LASS, J. Herpetic ganglionic latency: Acyclovir and vidarabine therapy. Arch. Ophthalmol. 1919; 91: 1508-1510.
• ⁴³
  PEPOSE, J.; NEWMAN, C.; BACH, M. - Pathologic features of cytomegalovirus retinopahty after treatment with the antiviral agent ganciclovir. Ophthalmlogy 1981; 94:414-424.
• ⁴⁴
  PORTER, S.; PATTERSON, A.; KHO, P. - A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis. Br. J. Ophthalmol. 1990; 14:283-285.
• ⁴⁵
  PRUSSOF,D. - Synthesis and biological activity of iododeoxyuridine, an analog of thymidine. Biochem. Biophys. Acta 1959; 32:295-296.
• ⁴⁶
  SCHAEFFER, H.; BEAUCHAMPS, J.; DE MIRANDA, P.; ELION, G.; BAUER, D.; COLLINS, P. - 9-(2-hydroxyethixymethyl) guanine activity against viruses of the herpes simplex group. Nature 1918; 272: 583-585.
• ⁴⁷
  SHUMAN, J.; ORELLANA, J.; FRIEDMAN, A. - Acquired immunodeficiency syndrome (AIDS). Surv. Ophthalmol. 1981; 31: 384-410.
• ⁴⁸
  SMEE, D.; MARTIN, J.; VERTHEYDEN, J.; MATTHEWS, T. - Anti-herpesvirus activity of the acyclic nucleoside guanine. Antimicrob. Agents Chemother. 1983; 30:616-682.
• ⁴⁹
  SPEAR, P. - Herpesviruses: Cell membrane and viral envelopes. Viroly 1980; 2:109-115.
• ⁵⁰
  SPEAR, P.; ROIZMAN, B. - Proteins specified by herpes simplex virus: V. Purification and structural proteins of the herpes virion. J. Virol. 1972; 9: 143-146.
• ⁵¹
  STUART-HARRIS, C. - Antiviral chemotherapy. London: Academic Press. Ltd, 1983: 1-12 (Oxford) Problems of antiviral chemotherapy.
• ⁵²
  TAMM, I. - Symposium on the experimental pharmacology and clinical use of antimetabolites. Clin. Pharmacol. Ther. 1960; 1:711-182.
• ⁵³
  TEICH, S.; CHEUNG, T.; FRIEDMAN, A. - Systemic antiviral drugs used in ophthalmology. Surv. Ophthalmol. 1992; 31: 19-53.
• ⁵⁴
  WORLD HEALTH ORGANIZATION. Report of a WHO informal consultation on preclinical and clinical aspects of the use immunomodulation in HIV infections. Report, 1989.

Datas de Publicação

• Publicação nesta coleção
  Dec 1993